Pan African Clinical Trials Registry

South African Medical Research Council, South African Cochrane Centre
PO Box 19070, Tygerberg, 7505, South Africa
Telephone: +27 21 938 0506 / +27 21 938 0834 Fax: +27 21 938 0836
Email: pactradmin@mrc.ac.za Website: pactr.samrc.ac.za
Trial no.: PACTR202006840710922 Date of Approval: 23/06/2020
Trial Status: Retrospective registration - This trial was registered after enrolment of the first participant
TRIAL DESCRIPTION
Public title Interrupted Direct Current stimulation, for Neuromuscular Recovery and Return to Walking after Traumatic Spinal cord injury : a Randomised Control Trial
Official scientific title Interrupted Direct Current stimulation for Neuromuscular Recovery and Return to Walking after Traumatic Spinal cord injury : a Randomised Control Trial
Brief summary describing the background and objectives of the trial Sequel to recent findings that implanted Interrupted Direct Current (IDC) in chronic spinal cord injred patients resulted in their return to walking, this study aims to investigate the impact and efficacy of IDC when applied transcutaneously and used to treat traumatic spinal cord injured patients in their first six months post injury.
Type of trial RCT
Acronym (If the trial has an acronym then please provide)
Disease(s) or condition(s) being studied Injury, Occupational Diseases, Poisoning,Nervous System Diseases,Spinal cord injury ,Surgery
Sub-Disease(s) or condition(s) being studied
Purpose of the trial Rehabilitation
Anticipated trial start date 09/06/2018
Actual trial start date 20/12/2018
Anticipated date of last follow up 30/09/2020
Actual Last follow-up date 26/03/2020
Anticipated target sample size (number of participants) 40
Actual target sample size (number of participants) 29
Recruitment status Closed to recruitment,follow-up continuing
Publication URL
Secondary Ids Issuing authority/Trial register
DCST HREC APP 2513 LAGOS UNIVERSITY TEACHING HOSPITAL HEALTH RESEARCH ETHICS COMMITTEE
OH 90 C IX NATIONAL ORTHOPAEDIC HOSPITAL IGBOBI HEALTH RESEARCH AND ETHICS COMMITTEE
FMCEB RET 0053 RESEARCH EDUCATION AND TRAINING DEPARTMENT FEDERAL MEDICAL CENTRE EBUTE META LAGOS
LREC 06 10 1123 LAGOS STATE UNIVERSITY TEACHING HOSPITAL HEALTH RESEARCH AND ETHICS COMMITTEE
STUDY DESIGN
Intervention assignment Allocation to intervention If randomised, describe how the allocation sequence was generated Describe how the allocation sequence/code was concealed from the person allocating the participants to the intervention arms Masking If masking / blinding was used
Factorial: participants randomly allocated to either no, one, some or all interventions simultaneously Randomised Simple randomization using by using procedures such as coin-tossing or dice-rolling Allocation was determined by the holder of the sequence who is situated off site Open-label(Masking Not Used)
INTERVENTIONS
Intervention type Intervention name Dose Duration Intervention description Group size Nature of control
Experimental Group Interrupted Direct Current plus Functional reeducation approach 0-350 Volts maximum (500ohms ), 1z-120Hz, 5 microseconds pulse duration and 100 microseconds inter pulse interval 3 times a week for 24 weeks per participant Participants in the experimental group received transcutaneous electrical stimulation following the Allen and Goodman schedule of electrical stimulation for new users with neurological conditions (). They received 5 minutes of trial stimulation of gluteal, quadriceps femoris, hamstrings, tibialis anterior, and soleus muscle groups, simultaneously with functional re-education approach in their first session. They had 15 minutes of stimulation per muscle group in their second and third sessions and 30 to 45 minutes of stimulation per muscle group, simultaneously with functional re-education approach from then on, 3 times a week, on alternate days for the 24 weeks period, for both lower limbs. Electrical stimulation was done in weight-bearing positions to stimulate sensory feedback. 15
Control Group Functional reeducation approach 30 to 60 minutes per session 30 to 60 minutes, 3 times a week for 24 weeks. All participants received functional re-education approach treatment 3 times a week, on alternate days of the week, for 24 weeks. The functional re-education approach received by all the participants commenced as soon as the patients were certified medically stable by the neurologists. As used in this study, the approach involved chest physiotherapy, passive, assisted active, active, and resisted active mobilization exercises, (depending on the level of recovery of the affected limbs) carried out for 3 bouts of 10 repetitions in all the joints of the affected limbs. Patients were positioned in bed to prevent/minimize contractures and bedsores and were taught active bed mobility exercises, and their caregivers/family members were involved in their care. Soft tissue stretching and mobilization exercises of 3 bouts of 10 repetitions per session were carried out. Various degrees of weight-bearing on the upper and lower extremities, on the exercise mat, between parallel bars, and on a tilt bed as well as facilitation of active movements in prone kneeling over inflatable vestibulation balls, two points kneeling and supported standing positions were done for about 30 minutes per patient. Facilitation of balanced long sitting and sitting cross-legged with upper extremity support, changing position from sitting to four points kneeling, to two points kneeling, to standing and supported walking was taught and done. Standing rehabilitation commenced in the third week using tilt-standing equipment with posterior leaf splint ankle-foot orthosis and back slab. They also wore a cervical collar and thoraco-lumbar-sacral corsets. Standing was done intermittently starting with 5 minutes and progressing by every 5 minutes when there was no complaint of dizziness or pain from any of the lower limb or/and intervertebral disc joints. Other functional rehabilitation was tailored toward the needs of the individual with specific attention to the pre-morbid functional performances. They were 14 Active-Treatment of Control Group
ELIGIBILITY CRITERIA
List inclusion criteria List exclusion criteria Age Category Minimum age Maximum age Gender
Individuals diagnosed with traumatic spinal cord injury (TSCI). Individuals with TSCI located at the fourth cervical vertebral level (C4) and below. Individuals with TSCI who can be assessed within one month of SCI injury or within the period of spinal shock. Individuals diagnosed with TSCI with progressive, or potentially progressive, spinal lesions including cancer and degenerative, or progressive vascular disorders of the spine and/or spinal cord. Individuals diagnosed with TSCI and other pre-morbid neurological conditions. Individuals diagnosed with altered cognitive status. Adolescent: 13 Year-18 Year,Adult: 19 Year-44 Year,Aged: 65+ Year(s),Middle Aged: 45 Year(s)-64 Year(s) 18 Year(s) 65 Year(s) Both
ETHICS APPROVAL
Has the study received appropriate ethics committee approval Date the study will be submitted for approval Date of approval Name of the ethics committee
Yes 24/10/2018 Health Research and Ethics Committee National Orthopaedic Hospital Igbobi
Ethics Committee Address
Street address City Postal code Country
120/124 Ikorodu Road Igbobi Lagos Igbobi, Lagos 101212 Nigeria
Has the study received appropriate ethics committee approval Date the study will be submitted for approval Date of approval Name of the ethics committee
Yes 06/12/2018 Lagos University Teaching Hospital Health Research Ethics Committee
Ethics Committee Address
Street address City Postal code Country
Idi Araba Lagos 12003 Nigeria
Has the study received appropriate ethics committee approval Date the study will be submitted for approval Date of approval Name of the ethics committee
Yes 11/01/2019 Lagos State University Teaching Hospital Health Research and Ethics Committee
Ethics Committee Address
Street address City Postal code Country
Ikeja Lagos Ikeja Lagos State 100271 Nigeria
Has the study received appropriate ethics committee approval Date the study will be submitted for approval Date of approval Name of the ethics committee
Yes 28/06/2019 Federal Medical Centre Ebute Meta Research Education and Training Department
Ethics Committee Address
Street address City Postal code Country
Railway Compound Ebute Meta Lagos Lagos State 1097 Nigeria
OUTCOMES
Type of outcome Outcome Timepoint(s) at which outcome measured
Primary Outcome The American Spinal Injury Association: International Standards for Neurological Classification of Spinal Cord Injury. This instrument is used to establish the neurological level of injury, as well as the severity of the lesion or impairment and rectal examination for voluntary anal contraction and anal sensation, in patients with SCI, using the following categories: A = Complete: No sensory or motor function is preserved in sacral segments S4-S5 B = Incomplete: Sensory, but not motor function is preserved below the neurologic level and extends through sacral segments S4-S5. C = Incomplete: Motor function is preserved below the neurologic level, and most key muscles below the neurologic level have a muscle grade of less than 3. D = Incomplete: Motor function is preserved below the neurologic level, and most key muscles below the neurologic level have a muscle grade that is greater than or equal to 3. E = Normal: Sensory and motor functions are normal. Use of the ASIA scale will assure uniformity in the patient population At point of initial assessment, at 6 weeks, 12 weeks, 18 weeks and 24 weeks.
Primary Outcome The Walking Index for Spinal Cord Injury II. The purpose of this scale is for use in clinical trials to measure improvements in walking in persons with spinal cord injury. The following outline describes subjects for whom the scale is most commonly utilized. 1. Spinal cord injury subjects who are capable of standing and walking in the parallel bars will be eligible for assessment. Only a reciprocal gait is to be considered in scoring the WISCI scale. Additional inclusion/exclusion criteria may be necessary. 2. Most often ASIA A below T10 and ASIA B, C, and D subjects may qualify. 3. Individuals with tetraplegia would require motor strength in triceps of at least grade 3 or be able to support their body weight. Standardized Physical Environment and Distance This is a functional limitation scale, not a disability scale. It must be used in a standardized environment with standardized equipment and definitions, which are observed and recorded by professional staffs that are trained. The subject is observed by the trained personnel and the WISCI level is recorded on the scale of 0 to 20 at baseline (Baseline WISCI). The subject is observed again at the defined interval (Interval WISCI). The change in score is calculated by subtracting the baseline WISCI from the Interval WISCI, which equals the change in WISCI (Changed WISCI). If a group of subjects are enrolled, medians and means may be calculated. At the point of first assessment, at 6 weeks, 12 weeks, 18 weeks and 24 weeks.
Primary Outcome Spinal Cord Independence Measure (SCIM) The SCIM was developed to address three specific areas of function in patients with spinal cord injuries (SCI). It looks at self-care (feeding, grooming, bathing, and dressing), respiration and sphincter management, and a patient’s mobility abilities (bed and transfers and indoors/outdoors). Additionally, the SCIM is also used to help guide clinicians in determining treatment goals and objectives for patients with an SCI. It is used by clinicians through direct observation of the activities listed or through patient report or interview information. The SCIM takes approximately 30-45 minutes to administer and score and is user friendly. Its scoring system is self-explanatory. Scores range from 0-100, where a score of 0 defines total dependence and a score of 100 is indicative of complete independence. Each subscale score is evaluated within the 100-point scale (self-care: 0-20; respiration and sphincter management: 0-40; mobility: 0-40). At point of first assessment, at 6 weeks, at 12 weeks, at 18 weeks and at 24 weeks.
Primary Outcome The Neuromuscular Recovery Scale (NRS) is a new and unique measure of the degree a person who has sustained a spinal cord injury (SCI) has recovered the ability to perform functional tasks relative to how the individual performed these tasks prior to injury (i.e. the same movement pattern and without compensation such as assistive device or substitution by another muscle). NRS is more effective than other measures (of balance, walking, or sensorimotor impairments) to classify SCI patients into functionally similar groups. The NRS may thus be a more sensitive instrument for assessing the therapeutic effect of an intervention tested in clinical trials and studies with the aim of achieving recovery after SCI. The NRS can provide the therapist and patient an effective means to quantify recovery, set goals, and assess progress. At point of first assessment, at 12 weeks and at 24 weeks.
Secondary Outcome Thigh Girth and Calf Girth is measured with the use of a measuring tape. The thigh girth is taken at 25 centimeters from the anterior superior iliac crest while the calf girth is taken at a point 25 centimeters from the lateral malleolus. This is to assess any changes in muscle bulk during the period of the study. At the point of first assessment, at 6 weeks, at 12 weeks, at 18 weeks and at 24 weeks.
RECRUITMENT CENTRES
Name of recruitment centre Street address City Postal code Country
Lagos University Teaching Hospital Idi-Araba Lagos 12003 Nigeria
National Orthopaedic Hospital Igbobi Yaba 120/124 Ikorodu Road Igbobi Lagos 101212 Nigeria
Federal Medical Centre Ebute Meta Railway Compound Ebute Meta 1097 Nigeria
Lagos State University Teaching Hospital Ikeja Lagos Nigeria
FUNDING SOURCES
Name of source Street address City Postal code Country
Dr Nkemakolam Fortunatus Ndionuka 7 Council Obule Close Akoka Yaba Lagos State 100213 Nigeria
SPONSORS
Sponsor level Name Street address City Postal code Country Nature of sponsor
Primary Sponsor Dr Nkemakolam Fortunatus Ndionuka Council Obule Close Akoka Lagos 100213 Nigeria Individual
COLLABORATORS
Name Street address City Postal code Country
No collaborator No collaborator None Nigeria
CONTACT PEOPLE
Role Name Email Phone Street address
Principal Investigator Eluemuno Ndionuka eluendionuka@gmail.com +2348028436085 Council Obule Close Akoka
City Postal code Country Position/Affiliation
Lagos 100213 Nigeria Doctoral Student
Role Name Email Phone Street address
Public Enquiries Olajide Olawale oolawale@unilag.edu.ng +2348080774586 Physiotherapy Department College of Medicine University of Lagos
City Postal code Country Position/Affiliation
Lagos 100254 Nigeria Professor and Supervisor
Role Name Email Phone Street address
Scientific Enquiries Caleb Gbiri cgbiri@unilag.edu.ng +2348033598072 Physiotherapy Department College of Medicine University of Lagos
City Postal code Country Position/Affiliation
Lagos 100254 Nigeria Senior Lecturer and Supervisor
REPORTING
Share IPD Description Additional Document Types Sharing Time Frame Key Access Criteria
Yes Summary results from study Clinical Study Report,Informed Consent Form,Statistical Analysis Plan,Study Protocol Individual Participant Data will be available for sharing from March 2021 Controlled. It will be made available for systematic review and comparative analysis to authors
URL Results Available Results Summary Result Posting Date First Journal Publication Date
Yes 11/07/2022
Result Upload 1: Result Upload 2: Result Upload 3: Result Upload 4: Result Upload 5:
Result - 11/07/2022 Result - 11/07/2022 Result - 11/07/2022 Result - 11/07/2022
Result URL Hyperlinks Link To Protocol
Result URL Hyperlinks
Changes to trial information